☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Biogen
The EC Approves Biogen’s Tofidence (Biosimilar, Roactemra) for Treating Arthritis and COVID-19
June 26, 2024
For an Aggregate of $1.8B, Biogen Acquires Human Immunology Biosciences to Strengthen its Immunology Portfolio
May 23, 2024
Biogen Receives EMA’s CHMP Positive Opinion for Tofidence (Biosimilar, Roactemra)
April 25, 2024
Biogen’s Qalsody (tofersen) Receives CHMP’s Positive Opinion for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
February 23, 2024
Biogen Receives the European Commission’s Approval for Skyclarys (omaveloxolone) to Treat Friedreich’s Ataxia (FA)
February 14, 2024
Kathleen Somera-Molina, Head of SMA Global Medical Affairs at Biogen Shares Insights on New SPINRAZA (nusinersen) Long-Term Data i...
August 7, 2023
Load more...
Back to Home